K
Description
Klaria is a listed Swedish pharmaceutical company based in Uppsala developing rapid-acting products based on its patented alginate transmucosal film platform. The film, similar to a small postage stamp, discreetly adheres to the oral mucosa and delivers the drug directly into the bloodstream. Pipeline: migraine (Sumatriptan - MAA approved in EU, launch 2026), cancer pain, opioid overdose and anaphylactic shock.